Abstract
Pleural lipoma is an extremely rare benign tumor. A lesion homogeneity with smooth borders is a suggestive criterion of lipoma in the chest radiology. Tissue biopsy is usually required for the diagnosis and exclusion of liposarcoma. In this case report, we described a female patient diagnosed with a pleural lipoma which was discovered accidentally during a metastatic work up of a previously diagnosed squamous cell carcinoma in the left ala nasi. The diagnosis of the pleural lipoma was histopathologically confirmed with tru cut biopsy.
Keywords: Intrathoracic lipoma, pleural lipoma, pleural tumor, tissue biopsy, liposarcoma, patient.
Current Respiratory Medicine Reviews
Title:Large Pleural Lipoma: An Incidental Finding During a Metastatic Workup
Volume: 14 Issue: 2
Author(s): Tamer Elhadidy, Raed Ali Elmetwally, Mohamed Tohlob, Mohamed Hamoda, Asem A. Hewidy and Ahmed Ehab*
Affiliation:
- Department of Chest Medicine, Faculty of Medicine, Mansoura University, Mansoura,Egypt
Keywords: Intrathoracic lipoma, pleural lipoma, pleural tumor, tissue biopsy, liposarcoma, patient.
Abstract: Pleural lipoma is an extremely rare benign tumor. A lesion homogeneity with smooth borders is a suggestive criterion of lipoma in the chest radiology. Tissue biopsy is usually required for the diagnosis and exclusion of liposarcoma. In this case report, we described a female patient diagnosed with a pleural lipoma which was discovered accidentally during a metastatic work up of a previously diagnosed squamous cell carcinoma in the left ala nasi. The diagnosis of the pleural lipoma was histopathologically confirmed with tru cut biopsy.
Export Options
About this article
Cite this article as:
Elhadidy Tamer, Elmetwally Ali Raed , Tohlob Mohamed, Hamoda Mohamed , Hewidy A. Asem and Ehab Ahmed*, Large Pleural Lipoma: An Incidental Finding During a Metastatic Workup, Current Respiratory Medicine Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573398X14666180510143814
DOI https://dx.doi.org/10.2174/1573398X14666180510143814 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer
Current Cancer Drug Targets Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery The Role of Biomarker Genes in the Diagnosis and Treatment of Nonsmall Cell Lung Cancer
Current Respiratory Medicine Reviews Compound Ranking Based on a New Mathematical Measure of Effectiveness Using Time Course Data from Cell-Based Assays
Combinatorial Chemistry & High Throughput Screening Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms
Current Drug Targets Molecular Signatures of Biomarkers in Cancer Development, Diagn osis, and its Prognostic Accuracy
Current Biomarkers (Discontinued) Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Current Cancer Therapy Reviews Neuroendocrine Tumors of the Lung: Hystological Classification, Diagnosis, Traditional and New Therapeutic Approaches
Current Medicinal Chemistry PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry Obesity and Cancer: Biological Links and Treatment Implications
Current Cancer Drug Targets Comparison of the Growth Curves of Cancer Cells and Cancer Stem Cells
Current Stem Cell Research & Therapy Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT
Current Pharmaceutical Design Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Current Cancer Drug Targets An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Editorial [ Hot Topic: Therapeutic Potential of Peptide Motifs - Part III (Executive Editor: Jean-Claude Herve) ]
Current Pharmaceutical Design The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Current Medicinal Chemistry Efficacy and Safety of EGFR Inhibitors in the Treatment of EGFRPositive NSCLC Patients: A Meta-Analysis
Reviews on Recent Clinical Trials Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design